The immune system in neurological diseases: What innate-like T cells have to say

The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology 2024-04, Vol.153 (4), p.913-923
Hauptverfasser: Wyatt-Johnson, Season K., Afify, Reham, Brutkiewicz, Randy R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 923
container_issue 4
container_start_page 913
container_title Journal of allergy and clinical immunology
container_volume 153
creator Wyatt-Johnson, Season K.
Afify, Reham
Brutkiewicz, Randy R.
description The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.
doi_str_mv 10.1016/j.jaci.2024.02.003
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928246370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S009167492400157X</els_id><sourcerecordid>2928246370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c307t-3832a211235ba33d8ab35e6771080892f137cbafad467ed9d620abaac504d61c3</originalsourceid><addsrcrecordid>eNp9kEtPwzAQhC0EoqXwBzggH7kkrO3ESRAXVPGSkOBQxNHa2FvqkgfECVL_PakKHDmtVjszmv0YOxUQCxD6Yh2v0fpYgkxikDGA2mNTAUUW6Vym-2wKUIhIZ0kxYUchrGHcVV4csonKlU5BpFP2vFgR93U9NMTDJvRUc9_whoaurdo3b7HizgfCQOGSv66wH88N9hRV_p34gluqqsBX-EW8b3nAzTE7WGIV6ORnztjL7c1ifh89Pt09zK8fI6sg66OxgUQphFRpiUq5HEuVks4yATnkhVwKldkSl-gSnZErnJaAJaJNIXFaWDVj57vcj679HCj0pvZh2wYbaodgZCFzmWiVwSiVO6nt2hA6WpqPztfYbYwAsyVp1mZL0mxJGpBmJDmazn7yh7Im92f5RTcKrnYCGr_88tSZYD01lpzvyPbGtf6__G9ugYOr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928246370</pqid></control><display><type>article</type><title>The immune system in neurological diseases: What innate-like T cells have to say</title><source>Access via ScienceDirect (Elsevier)</source><creator>Wyatt-Johnson, Season K. ; Afify, Reham ; Brutkiewicz, Randy R.</creator><creatorcontrib>Wyatt-Johnson, Season K. ; Afify, Reham ; Brutkiewicz, Randy R.</creatorcontrib><description>The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.</description><identifier>ISSN: 0091-6749</identifier><identifier>EISSN: 1097-6825</identifier><identifier>DOI: 10.1016/j.jaci.2024.02.003</identifier><identifier>PMID: 38365015</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>CD1d ; CNS diseases ; MAIT cells ; MR1 ; neuroimmunology ; neuroinflammation ; NKT cells ; γδ T cells</subject><ispartof>Journal of allergy and clinical immunology, 2024-04, Vol.153 (4), p.913-923</ispartof><rights>2024 American Academy of Allergy, Asthma &amp; Immunology</rights><rights>Copyright © 2024. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c307t-3832a211235ba33d8ab35e6771080892f137cbafad467ed9d620abaac504d61c3</cites><orcidid>0000-0002-7396-480X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaci.2024.02.003$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38365015$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wyatt-Johnson, Season K.</creatorcontrib><creatorcontrib>Afify, Reham</creatorcontrib><creatorcontrib>Brutkiewicz, Randy R.</creatorcontrib><title>The immune system in neurological diseases: What innate-like T cells have to say</title><title>Journal of allergy and clinical immunology</title><addtitle>J Allergy Clin Immunol</addtitle><description>The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.</description><subject>CD1d</subject><subject>CNS diseases</subject><subject>MAIT cells</subject><subject>MR1</subject><subject>neuroimmunology</subject><subject>neuroinflammation</subject><subject>NKT cells</subject><subject>γδ T cells</subject><issn>0091-6749</issn><issn>1097-6825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kEtPwzAQhC0EoqXwBzggH7kkrO3ESRAXVPGSkOBQxNHa2FvqkgfECVL_PakKHDmtVjszmv0YOxUQCxD6Yh2v0fpYgkxikDGA2mNTAUUW6Vym-2wKUIhIZ0kxYUchrGHcVV4csonKlU5BpFP2vFgR93U9NMTDJvRUc9_whoaurdo3b7HizgfCQOGSv66wH88N9hRV_p34gluqqsBX-EW8b3nAzTE7WGIV6ORnztjL7c1ifh89Pt09zK8fI6sg66OxgUQphFRpiUq5HEuVks4yATnkhVwKldkSl-gSnZErnJaAJaJNIXFaWDVj57vcj679HCj0pvZh2wYbaodgZCFzmWiVwSiVO6nt2hA6WpqPztfYbYwAsyVp1mZL0mxJGpBmJDmazn7yh7Im92f5RTcKrnYCGr_88tSZYD01lpzvyPbGtf6__G9ugYOr</recordid><startdate>20240401</startdate><enddate>20240401</enddate><creator>Wyatt-Johnson, Season K.</creator><creator>Afify, Reham</creator><creator>Brutkiewicz, Randy R.</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7396-480X</orcidid></search><sort><creationdate>20240401</creationdate><title>The immune system in neurological diseases: What innate-like T cells have to say</title><author>Wyatt-Johnson, Season K. ; Afify, Reham ; Brutkiewicz, Randy R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c307t-3832a211235ba33d8ab35e6771080892f137cbafad467ed9d620abaac504d61c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>CD1d</topic><topic>CNS diseases</topic><topic>MAIT cells</topic><topic>MR1</topic><topic>neuroimmunology</topic><topic>neuroinflammation</topic><topic>NKT cells</topic><topic>γδ T cells</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wyatt-Johnson, Season K.</creatorcontrib><creatorcontrib>Afify, Reham</creatorcontrib><creatorcontrib>Brutkiewicz, Randy R.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of allergy and clinical immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wyatt-Johnson, Season K.</au><au>Afify, Reham</au><au>Brutkiewicz, Randy R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The immune system in neurological diseases: What innate-like T cells have to say</atitle><jtitle>Journal of allergy and clinical immunology</jtitle><addtitle>J Allergy Clin Immunol</addtitle><date>2024-04-01</date><risdate>2024</risdate><volume>153</volume><issue>4</issue><spage>913</spage><epage>923</epage><pages>913-923</pages><issn>0091-6749</issn><eissn>1097-6825</eissn><abstract>The immune system classically consists of 2 lines of defense, innate and adaptive, both of which interact with one another effectively to protect us against any pathogenic threats. Importantly, there is a diverse subset of cells known as innate-like T cells that act as a bridge between the innate and adaptive immune systems and are pivotal players in eliciting inflammatory immune responses. A growing body of evidence has demonstrated the regulatory impact of these innate-like T cells in central nervous system (CNS) diseases and that such immune cells can traffic into the brain in multiple pathological conditions, which can be typically attributed to the breakdown of the blood-brain barrier. However, until now, it has been poorly understood whether innate-like T cells have direct protective or causative properties, particularly in CNS diseases. Therefore, in this review, our attention is focused on discussing the critical roles of 3 unique subsets of unconventional T cells, namely, natural killer T cells, γδ T cells, and mucosal-associated invariant T cells, in the context of CNS diseases, disorders, and injuries and how the interplay of these immune cells modulates CNS pathology, in an attempt to gain a better understanding of their complex functions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>38365015</pmid><doi>10.1016/j.jaci.2024.02.003</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0002-7396-480X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0091-6749
ispartof Journal of allergy and clinical immunology, 2024-04, Vol.153 (4), p.913-923
issn 0091-6749
1097-6825
language eng
recordid cdi_proquest_miscellaneous_2928246370
source Access via ScienceDirect (Elsevier)
subjects CD1d
CNS diseases
MAIT cells
MR1
neuroimmunology
neuroinflammation
NKT cells
γδ T cells
title The immune system in neurological diseases: What innate-like T cells have to say
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A09%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20immune%20system%20in%20neurological%20diseases:%20What%20innate-like%20T%20cells%20have%20to%20say&rft.jtitle=Journal%20of%20allergy%20and%20clinical%20immunology&rft.au=Wyatt-Johnson,%20Season%20K.&rft.date=2024-04-01&rft.volume=153&rft.issue=4&rft.spage=913&rft.epage=923&rft.pages=913-923&rft.issn=0091-6749&rft.eissn=1097-6825&rft_id=info:doi/10.1016/j.jaci.2024.02.003&rft_dat=%3Cproquest_cross%3E2928246370%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928246370&rft_id=info:pmid/38365015&rft_els_id=S009167492400157X&rfr_iscdi=true